EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies
Executive Summary
The European Medicines Agency’s endorsement of a framework that explains how drug and medical device sponsors can use patient preference studies to answer their research questions could help increase confidence in the conduct and acceptability of such studies.
You may also be interested in...
Guidance On Harmonization Of Patient-Focused Drug Development Is Years Away
The International Council for Harmonization has proposed topics for a global PFDD guideline and is expected to begin work on it in the next few years. When finalized, the US FDA will issue it as draft guidance.
EMA Consults On Proposed Framework For Patient Preference Studies
The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.